Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Intervention to Improve Outcomes in Patients With Advanced Cancer (TEAMS)

This study has been completed.
National Institute of Nursing Research (NINR)
Information provided by (Responsible Party):
Yale University Identifier:
First received: January 5, 2011
Last updated: June 13, 2016
Last verified: June 2016
1.) To integrate discharge planning into an intervention provided by advanced practice nurses (APRNs)for patients with advanced cancer, 2.) To evaluate the effects of the intervention, and 3.) To explore the reach, adoption, and implementation of the intervention to facilitate the transition of patients from surgery/biopsy/chemotherapy to medical oncology in a comprehensive cancer center.

Condition Intervention Phase
Behavioral: Symptom Education
Behavioral: Intervention
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: An Intervention to Improve Outcomes in Patients With Advanced Cancer

Resource links provided by NLM:

Further study details as provided by Yale University:

Primary Outcome Measures:
  • Uncertainty [ Time Frame: 1 month post baseline ] [ Designated as safety issue: No ]
    The MUIS-C contains 23 Likert scale items with scores that range from 1= strongly disagree to 5= strongly agree.

  • Uncertainty [ Time Frame: 3 months post-baseline ] [ Designated as safety issue: No ]
    The MUIS-C is a 23-item scale that asks the respondent to rate items on a scale of 1=strongly disagree to 5= strongly agree.

Secondary Outcome Measures:
  • HADS- Anxiety [ Time Frame: 1 month post baseline ] [ Designated as safety issue: No ]
    7 items are rated on a 4-point scale.

  • HADS-Anxiety [ Time Frame: 3 months post baseline. ] [ Designated as safety issue: No ]
    7 items are rated on a 4-point scale.

Enrollment: 146
Study Start Date: September 2009
Study Completion Date: August 2013
Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Information/Education Group
Assistance in using Symptom Management Toolkit
Behavioral: Symptom Education
Participants are given a Symptom Education Toolkit at baseline and at each visit thereafter (1 month and 3 month) are encouraged to use the Toolkit for symptoms they are experiencing. They are also encouraged to use resources available to them.
Experimental: Nurse Intervention
Participants are given intensive nurse contacts to reduce uncertainty and maximize problem solving, and later, to transition to the treatment phase of their cancer.
Behavioral: Intervention
Participants are visited/contacted by an intervention nurse ten times over a 12-week period for the purpose of helping them to manage uncertainty and distress,to boost their problem-solving skills, and to transition to treatment.


Ages Eligible for Study:   21 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • primary diagnosis of advanced lung, GI, Head & Neck, and Lung cancers
  • post-surgical/or post-biopsy with physician's order for cancer treatment
  • age 21 years or older
  • lives within 50 of Yale New Haven Hospital
  • has 2 or more co-morbid conditions
  • has an emotional distress thermometer score of greater than or equal to 4-

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01272024

United States, Connecticut
Yale New Haven Hospital/Smilow Cancer Hospital
New Haven, Connecticut, United States, 06510
Sponsors and Collaborators
Yale University
National Institute of Nursing Research (NINR)
Principal Investigator: Ruth McCorkle, RN, PhD Yale University
  More Information

Responsible Party: Yale University Identifier: NCT01272024     History of Changes
Other Study ID Numbers: 0909005722  R01NR011872 
Study First Received: January 5, 2011
Last Updated: June 13, 2016
Health Authority: United States: Federal Government

Keywords provided by Yale University:
clinical trial
symptom education
advanced cancer processed this record on October 27, 2016